Entera Bio (ENTX) EPS (Basic) Growth (5y) (2024 - 2026)

Entera Bio (ENTX) EPS (Basic) Growth (5y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.05 Bn	131.20 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.99 Bn	78.00 Bn	3.93 Bn
3	Argenx Se	65.49 Bn	60.31 Bn	1.37 Bn
4	Moderna	56.79 Bn	51.65 Bn	52.00 Mn
5	BeOne Medicines	42.14 Bn	37.05 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.27 Bn	992.69 Mn
7	BioNTech SE	27.71 Bn	9.32 Bn	668.28 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
9	Royalty Pharma	27.35 Bn	26.51 Bn	-
10	Entera Bio	164.72 Mn	153.41 Mn	-

Download Data